FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/10/037409 [Registered on: 20/10/2021] Trial Registered Prospectively
Last Modified On: 14/05/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A Clinical Trial to Compare And Study The Effects Of Enhanced Recovery After Surgery (ERAS) Protocol Vs Conventional Care In Patients Undergoing surgery For Brain Aneurysm 
Scientific Title of Study   Comparison Of Enhanced Recovery After Surgery(ERAS) Protocol Vs Conventional Care In Patients Undergoing Elective Craniotomy For Intracranial Aneurysms: A Randomized Controlled Trial 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
Nil  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Pandit Sneha Amar  
Designation  Senior Resident (DM) 
Affiliation  All India Institute Of Medical Sciences,New Delhi 
Address  6th floor, Neurosciences Centre, Department of Neuroanaesthesia And Critical Care , All India Institute Of Medical Sciences, Ansari Nagar, New Delhi

South
DELHI
110029
India 
Phone  8447164004  
Fax    
Email  snehadocuments2017@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Indu Kapoor 
Designation  Associate Professor,department of neuroanesthesia and critical care 
Affiliation  All India Institute Of Medical Sciences 
Address  6th floor,Neurosciences Centre, Department of Neuroanaesthesia And Critical Care ,All India Institute Of Medical Sciences, Ansari Nagar, New Delhi

South
DELHI
110029
India 
Phone  9013439134  
Fax    
Email  dr.indu.me@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sneha Pandit 
Designation  Senior Resident (DM) 
Affiliation  All India Institute Of Medical Sciences 
Address  6th floor,Neurosciences Centre, department of NeuroAnaesthesia and critical care , All india institute of medical sciences, Ansari nagar,new delhi ,delhi,110029

South
DELHI
110029
India 
Phone  08447164004  
Fax    
Email  snehadocuments2017@gmail.com  
 
Source of Monetary or Material Support  
All india institute of medical sciences 
 
Primary Sponsor  
Name  All india institute of medical sciences 
Address  6th floor,Department of neuroanesthesia and critical care,neurosciences centre, AIIMS, new delhi 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Pandit Sneha Amar  All India Institute Of Medical Sciences  6th floor,Department of Neuroanaesthesia And Critical Care,neurosciences centre, All India Institute Of Medical Sciences, Ansari Nagar, New Delhi,110029
South
DELHI 
8447164004

snehadocuments2017@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Aiims Institutional Ethics Committee,AIIMS room no 102,first floor old OT Block, AIIMS,New Delhi  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: I609||Nontraumatic subarachnoid hemorrhage, unspecified, (2) ICD-10 Condition: I671||Cerebral aneurysm, nonruptured,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Conventional care in perioperative period  This group will be managed as per existing practices at institution. Preoperatively patients will be counselled regarding the risk and benefit of the surgery and for abstinence from both alcohol and smoking when admitted. Patient will be advised for overnight fasting before the surgery. Use of mechanical DVT prophylaxis will be as per discretion of anaesthesiologist and surgical team. In Intraoperative period, patients will receive antibiotics prophylaxis within 1 hour of skin incision and routine skin preparation. Induction and maintenance of anaesthesia will be according to standard institutional procedure with either TIVA or balanced anaesthesia. intraoperative analgesic management will be taken care by fentanyl infusion 1-2 mcg/kg /hr and boluses as per requirement. Intraoperative fluid management will be done by clinical monitoring. Measures to prevent hypothermia will be implemented with help of Forced air warmers and warm IV fluid infusion. In postoperative period, patients will receive antiemetic treatment as per requirement if they complaint of nausea or vomiting. Use of mechanical DVT prophylaxis will be as per discretion of anaesthesiologist and surgical team. Decision of restoration of and mobilization diet and urinary catheter removal will be done as per institutional protocol.  
Intervention  ERAS protocol in perioperative period  Patients will be counselled regarding the risk and benefit of the surgery and for abstinence from both alcohol and smoking when admitted. They will be advised for overnight fasting before the surgery. Mechanical DVT prophylaxis (either with use of graduated compression stockings or intermittent pneumatic compression devices) will be applied, and will bescored according to Apfel PONV risk assessment scale In Intraoperative period, patients will be receiving mechanical DVT prophylaxis in form of graduated compression stockings or intermittent pneumatic compression devices. They will receive Antibiotics prophylaxis within 1 hour of skin incision and routine skin preparation. Induction and maintenance of anaesthesia will be according to standard institutional procedure with either TIVA or balanced anaesthesia. After induction and before the start of surgery ERAS group will receive complete bilateral Scalp block with 0.25% bupivacaine.Dexmedetomidine drug infusion will be started in dose of 0.2-0.7 mcg/kg/hr in maintenance phase of anaesthesia and Fentanyl boluses 0.5-1mcg/kg will be given as per requirement. Intraoperative fluid management will be done according to Cardiac output Goal directed therapy. Measures to prevent hypothermia will be implemented for with help of Forced air warmers and warm IV fluid infusion. In Postoperative period, PONV prophylaxis with ondansetron 0.15 mg/kg will be received by patients if PONV risk assessment score ≥ 3 before extubation or antiemetic drugs will be administered to patient if they complaint of nausea and vomiting. Patients will be receiving postoperative mechanical DVT Prophylaxis measures.We will attempt for early urinary catheter removal in ERAS subjects and Patients will be encouraged for early restoration of diet and mobilization.  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1.Patient who gives Informed Consent
2.Patients with anterior circulation aneurysms with World Federation of Neurosurgical Societies(WFNS) grade 1
3.ASA grade 1 and 2
4.GCS 15/15
 
 
ExclusionCriteria 
Details  1.Patients not giving consent
2.Patients with posterior circulation aneurysm
3.World Federation of Neurosurgical Societies (WFNS) grade 2,3,4 and 5
4.Age less than 18 years and more than 65 years
5.ASA grade 3,4,5
6. Pregnant patients
7. Patient requiring postoperative ventilation
8. History of previous brain surgery
9. Preoperative cognitive dysfunction
10. BMI > 40
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
length of stay in hospital  at discharge  
 
Secondary Outcome  
Outcome  TimePoints 
Fentanyl consumption
 
In intraoperative period 
Pain assessment by Numerical Rating Score (NRS) pain score  In Postoperative period at every 2 hour interval for 24 hours 
Analgesic requirement   In Postoperative period at 24 hours 
Antiemetic requirement in 24 hours  In Postoperative period at 24 hours 
Length of ICU stay  duration of stay in ICU after surgery 
Functional recovery  discharge,1 month and 3 months 
Patient satisfaction score   discharge 
postoperative complications both surgical(surgical site infection, intracranial infection, epilepsy, haemorrhage, rebleeding , vasospasm etc) and non-surgical complications (respiratory complications, cardiovascular complications gastrointestinal complications, urinary tract complications, and venous thromboembolism etc )  at discharge 
 
Target Sample Size   Total Sample Size="46"
Sample Size from India="46" 
Final Enrollment numbers achieved (Total)= "46"
Final Enrollment numbers achieved (India)="46" 
Phase of Trial   N/A 
Date of First Enrollment (India)   31/10/2021 
Date of Study Completion (India) 30/06/2023 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) 30/06/2023 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   None yet  
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

This study is a randomized control trial, single center study comparing the efficacy of enhanced recovery after surgery (ERAS) protocol vs conventional care in 46 patients who will be undergoing elective craniotomy for intracranial aneurysm  that will be conducted in neurosciences centre , All India institute of medical sciences, New Delhi. The primary outcome measures will be length of stay in hospital. Secondary outcomes will be Intraoperative fentanyl consumption, Postoperative pain assessment by Numerical Rating Score (NRS) pain score every 2 hours for 24 hours, Postoperative analgesic requirement in 24 hours, Postoperative antiemetic requirement in 24 hours, Length of ICU stay, Any Complications (surgical and non-surgical) till discharge, Functional recovery at discharge,1month and 3 months and Patient satisfaction score at discharge

 


 
Close